Central Pacific Bank - Trust Division’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-400
Closed -$5.74K – 891
2026
Q1
$5.74K Hold
400
– – ﹤0.01% 731
2025
Q4
$6.02K Hold
400
– – ﹤0.01% 719
2025
Q3
$5.77K Hold
400
– – ﹤0.01% 725
2025
Q2
$5.7K Hold
400
– – ﹤0.01% 735
2025
Q1
$5.96K Hold
400
– – ﹤0.01% 735
2024
Q4
$5.76K Hold
400
– – ﹤0.01% 757
2024
Q3
$6.34K Hold
400
– – ﹤0.01% 731
2024
Q2
$6.14K Hold
400
– – ﹤0.01% 812
2024
Q1
$6.54K Buy
+400
New +$6.31K ﹤0.01% 806

Other funds holding BMEZ

Central Pacific Bank - Trust Division's BMEZ Position: Q2 2026 in Review

Central Pacific Bank - Trust Division sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2026, closing a stake of 400 shares — an estimated $5.74K sold.

Central Pacific Bank - Trust Division first reported a position in BMEZ in Q1 2024 and held it in 9 quarters. The position peaked at $6.54K in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Central Pacific Bank - Trust Division reported no remaining BlackRock Health Sciences Trust II position as of Q2 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 400 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $5.74K.
  • Central Pacific Bank - Trust Division first reported a position in BlackRock Health Sciences Trust II in Q1 2024 and held it in 9 quarters.
  • Central Pacific Bank - Trust Division's BlackRock Health Sciences Trust II position peaked at $6.54K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.